Cargando…
Drug delivery systems for RNA therapeutics
RNA-based gene therapy requires therapeutic RNA to function inside target cells without eliciting unwanted immune responses. RNA can be ferried into cells using non-viral drug delivery systems, which circumvent the limitations of viral delivery vectors. Here, we review the growing number of RNA ther...
Autores principales: | Paunovska, Kalina, Loughrey, David, Dahlman, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724758/ https://www.ncbi.nlm.nih.gov/pubmed/34983972 http://dx.doi.org/10.1038/s41576-021-00439-4 |
Ejemplares similares
-
Increased PIP3 activity blocks nanoparticle mRNA delivery
por: Paunovska, Kalina, et al.
Publicado: (2020) -
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands
por: Gan, Zubao, et al.
Publicado: (2020) -
High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing
por: Sago, Cory D., et al.
Publicado: (2018) -
The Transcriptional
Response to Lung-Targeting Lipid
Nanoparticles in Vivo
por: Radmand, Afsane, et al.
Publicado: (2023) -
Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
por: Jongejan, Yvonne K., et al.
Publicado: (2023)